Cargando…
Short‐acting β(2)‐agonist use and asthma exacerbations in Swedish children: A SABINA Junior study
BACKGROUND: In adults and adolescents with asthma, use of ≥3 short‐acting β(2)‐agonist (SABA) canisters/year is associated with increased exacerbation risk. Whether this association is present in younger children remains unknown. In this SABA use IN Asthma (SABINA) Junior study, we assessed the asso...
Autores principales: | Melén, Erik, Nwaru, Bright I., Wiklund, Fredrik, de Fine Licht, Sofie, Telg, Gunilla, Maslova, Ekaterina, van der Valk, Ralf J. P., Tran, Trung N., Ekström, Magnus, Janson, Christer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828275/ https://www.ncbi.nlm.nih.gov/pubmed/36433853 http://dx.doi.org/10.1111/pai.13885 |
Ejemplares similares
-
Overuse of short-acting β(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme
por: Nwaru, Bright I., et al.
Publicado: (2020) -
Management and Risk of Mortality in Patients Hospitalised Due to a First Severe COPD Exacerbation
por: Janson, Christer, et al.
Publicado: (2020) -
Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care
por: Sandelowsky, Hanna, et al.
Publicado: (2022) -
Annual and Post-Exacerbation Follow-Up of Asthma Patients in Clinical Practice – A Large Population-Based Study in Sweden
por: Sandelowsky, Hanna, et al.
Publicado: (2022) -
Short-acting β(2)-agonists and exacerbations in children with asthma in England: SABINA Junior
por: Morgan, Ann, et al.
Publicado: (2023)